- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02955017
Mobile Health Intervention (MHI)
Use of New Technologies for the Follow-up in Adolescent Obesity
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Childhood obesity continues to be a key challenge in France. The unit is facing a high demand with limited resources, moreover despite an intensive program of care with a multidisciplinary dedicated team, the impact on weight loss is moderate.
The hypothesis is to ameliorate results by using distance monitoring in maintenance phase.
After a traditional intensive period consisting in a weekly family-based multidisciplinary intervention, patients are randomized in two arms, traditional or distance follow-up.
Traditional follow-up is based on face-to-face multidisciplinary consultations every three months.
The distance monitoring is based on a mobile application dedicated to food behavior change and physical activity, with weekly self-monitoring, goal setting, physical activity and healthy eating support, monthly weight assessment. Pre-programmed feedbacks "motivational strategies" are included.
After one year of follow-up, adolescents are evaluated for weight loss, compliance and quality of life. The two groups will be compared.
The question is can mobile apps help to monitor and promote healthy lifestyle in obese adolescents.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Paris
-
Paris, Paris, France, 75015
- Necker-Enfants Malades Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 11-17 years old
- Body Mass Index > 97th percentile using French reference
- Non Syndromic obesity
- Appropriate understanding of the study
- Appropriate understanding of french language, and ability in writing and reading
Exclusion Criteria:
- Mental disability, severe and uncontrolled psychiatric disorders.
- Syndromic obesity, endocrine disorders or drug-induced obesity
- Other therapeutic: bariatric surgery, medications for weight loss
- Enrolment in an other therapeutic study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Traditional follow-up
|
|
|
Experimental: Distance follow-up "new technologies"
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline in Body Mass Index Z-score
Time Frame: 15 months
|
Body mass index z score is calculated using french reference data.
success: decrease of Body Mass Index Z-score from baseline to 15 months of 0.5 standard deviation
|
15 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in mean difference of Body Mass Index Z-score between the two groups
Time Frame: 15 months
|
15 months
|
|
|
Percent of loss to follow-up
Time Frame: 15 months
|
15 months
|
|
|
Change from baseline in PedsQL score
Time Frame: 15 months
|
15 months
|
|
|
Change from baseline in Eating Behavior assessed by a dietitian from a questionnaire
Time Frame: 15 months
|
15 months
|
|
|
Change from baseline in Physical activity and sedentary behavior assessed by the number of hours of physical activity per week
Time Frame: 15 months
|
15 months
|
|
|
Glycemia (mmol/l)
Time Frame: 15 months
|
Change from baseline in metabolic syndrome
|
15 months
|
|
Fasting insulinemia (µmol/l)
Time Frame: 15 months
|
Change from baseline in metabolic syndrome
|
15 months
|
|
Homeostasis Model assessment (HOMA)
Time Frame: 15 months
|
Change from baseline in metabolic syndrome
|
15 months
|
|
Dyslipidemia (mmol/l)
Time Frame: 15 months
|
Change from baseline in metabolic syndrome
|
15 months
|
|
Blood pressure (mmHg)
Time Frame: 15 months
|
Change from baseline in metabolic syndrome
|
15 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Myriam DABBAS, MD, Assistance Publique - Hôpitaux de Paris
Publications and helpful links
General Publications
- O'Malley G, Clarke M, Burls A, Murphy S, Murphy N, Perry IJ. A smartphone intervention for adolescent obesity: study protocol for a randomised controlled non-inferiority trial. Trials. 2014 Jan 31;15:43. doi: 10.1186/1745-6215-15-43.
- Turner T, Spruijt-Metz D, Wen CK, Hingle MD. Prevention and treatment of pediatric obesity using mobile and wireless technologies: a systematic review. Pediatr Obes. 2015 Dec;10(6):403-9. doi: 10.1111/ijpo.12002. Epub 2015 Jan 12.
- Pretlow RA, Stock CM, Allison S, Roeger L. Treatment of child/adolescent obesity using the addiction model: a smartphone app pilot study. Child Obes. 2015 Jun;11(3):248-59. doi: 10.1089/chi.2014.0124. Epub 2015 Mar 11.
- Svetkey LP, Batch BC, Lin PH, Intille SS, Corsino L, Tyson CC, Bosworth HB, Grambow SC, Voils C, Loria C, Gallis JA, Schwager J, Bennett GG. Cell phone intervention for you (CITY): A randomized, controlled trial of behavioral weight loss intervention for young adults using mobile technology. Obesity (Silver Spring). 2015 Nov;23(11):2133-41. doi: 10.1002/oby.21226.
- Foissac F, Lepage G, Briand N, Cosnefroy M, Charrat A, Dabbas M. Mobile Health Is a Cost-Effective Strategy for Managing Obesity in Adolescents: A Randomised Controlled Trial. Acta Paediatr. 2025 Jul 24. doi: 10.1111/apa.70248. Online ahead of print.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016-A00666-45
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on traditional follow_up
-
M.D. Anderson Cancer CenterCompletedRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
Peking University Third HospitalNot yet recruiting
-
Henan University of Traditional Chinese MedicineThe First Affiliated Hospital of Zhengzhou University; China-Japan Friendship... and other collaboratorsNot yet recruiting
-
IRCCS San RaffaeleCompleted
-
Peking Union Medical College HospitalGuangdong Provincial Hospital of Traditional Chinese Medicine; Peking University... and other collaboratorsRecruitingFunctional Hypothalamic AmenorrheaChina
-
Peking Union Medical College HospitalShandong University; Guangdong Provincial Hospital of Traditional Chinese Medicine and other collaboratorsNot yet recruitingInfertility | Diminished Ovarian Reserve (DOR)China
-
Qianfoshan HospitalNot yet recruitingHepatic Encephalopathy | Cirrhosis, Liver | Portosystemic ShuntChina
-
Shengjing HospitalRecruitingPlasma Cell MastitisChina
-
Superior UniversityActive, not recruiting
-
University of Alabama at BirminghamNot yet recruitingDiabetic Macular Edema (DME)United States